MiR-7-5p suppresses cell proliferation and induces apoptosis of breast cancer cells mainly by targeting REGγ

Cancer Letters

Volumn 358, Issue 1, 2015, Pages 27-36

  Shi, Yuan ^a,b   Luo, Xinrong ^a   Li, Peng ^a   Tan, Jinxiang ^a   Wang, Xiaoyi ^a   Xiang, Tingxiu ^a   Ren, Guosheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; MiR 7 5p; Proliferation; REG

Indexed keywords

CASPASE 3; KI 67 ANTIGEN; MICRORNA; MICRORNA 7 5P; PROTEASOME; PROTEASOME ACTIVATOR SUBUNIT 3; PROTEIN P21; PROTEIN P27; UNCLASSIFIED DRUG; AUTOANTIGEN; KI ANTIGEN; MIRN7 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CANCER PROGNOSIS; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RNA BINDING; REG GAMMA GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; UPREGULATION; BIOSYNTHESIS; BREAST TUMOR; DRUG SCREENING; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; MCF 7 CELL LINE; PATHOLOGY;

APOPTOSIS; AUTOANTIGENS; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MCF-7 CELLS; MICRORNAS; PROTEASOME ENDOPEPTIDASE COMPLEX; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84921288964     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.12.014     Document Type: Article

References (32)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin 2011, 61:69-90.
2. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
3. Wang X., Tu S., Tan J., Tian T., Ran L., Rodier J.F., et al. REG gamma: a potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell. Med. Oncol 2011, 28:31-41.
4. Tian M., Xiaoyi W., Xiaotao L., Guosheng R. Proteasomes reactivator REG gamma enhances oncogenicity of MDA-MB-231 cell line via promoting cell proliferation and inhibiting apoptosis. Cell. Mol. Biol. (Noisy-Le-Grand) 2009, 55(Suppl.):OL1121-OL1131.
5. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
6. Fang Y., Xue J.L., Shen Q., Chen J., Tian L. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology 2012, 55:1852-1862.
7. Kong X., Li G., Yuan Y., He Y., Wu X., Zhang W., et al. MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression. PLoS ONE 2012, 7. e41523.
8. Okuda H., Xing F., Pandey P.R., Sharma S., Watabe M., Pai S.K., et al. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res 2013, 73:1434-1444.
9. Xiong S., Zheng Y., Jiang P., Liu R., Liu X., Qian J., et al. PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer. Br. J. Cancer 2014, 110:353-362.
10. Yu Z., Ni L., Chen D., Zhang Q., Su Z., Wang Y., et al. Identification of miR-7 as an oncogene in renal cell carcinoma. J. Mol. Histol 2013, 44:669-677.
11. Zhang M., Gan L., Ren G.S. REGgamma is a strong candidate for the regulation of cell cycle, proliferation and the invasion by poorly differentiated thyroid carcinoma cells. Braz. J. Med. Biol. Res 2012, 45:459-465.
12. Xiang T., Li L., Yin X., Zhong L., Peng W., Qiu Z., et al. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/beta-catenin signalling and apoptosis regulation in breast cancer cells. J. Cell. Mol. Med 2013, 17:1236-1246.
13. Li L., Ying J., Tong X., Zhong L., Su X., Xiang T., et al. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting beta-catenin and AKT signaling but frequently methylated in common carcinomas. Cell. Mol. Life Sci 2014, 71:2179-2192.
14. Xiang T., Li L., Yin X., Yuan C., Tan C., Su X., et al. The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer. PLoS ONE 2012, 7. e29783.
15. Yin X., Xiang T., Li L., Su X., Shu X., Luo X., et al. DACT1, an antagonist to Wnt/beta-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer. Breast Cancer Res 2013, 15. R23.
16. Liu B.Q., Meng X., Li C., Gao Y.Y., Li N., Niu X.F., et al. Glucosamine induces cell death via proteasome inhibition in human ALVA41 prostate cancer cell. Exp. Mol. Med 2011, 43:487-493.
17. Gao G., Wong J., Zhang J., Mao I., Shravah J., Wu Y., et al. Proteasome activator REGgamma enhances coxsackieviral infection by facilitating p53 degradation. J. Virol 2010, 84:11056-11066.
18. Li X., Amazit L., Long W., Lonard D.M., Monaco J.J., O'Malley B.W. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol. Cell 2007, 26:831-842.
19. Chen X., Barton L.F., Chi Y., Clurman B.E., Roberts J.M. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol. Cell 2007, 26:843-852.
20. Zhu S., Si M.L., Wu H., Mo Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem 2007, 282:14328-14336.
21. Sachdeva M., Zhu S., Wu F., Wu H., Walia V., Kumar S., et al. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3207-3212.
22. Mulrane L., McGee S.F., Gallagher W.M., O'Connor D.P. miRNA dysregulation in breast cancer. Cancer Res 2013, 73:6554-6562.
23. Kefas B., Godlewski J., Comeau L., Li Y., Abounader R., Hawkinson M., et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 2008, 68:3566-3572.
24. Webster R.J., Giles K.M., Price K.J., Zhang P.M., Mattick J.S., Leedman P.J. Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J. Biol. Chem 2009, 284:5731-5741.
25. Xie J., Chen M., Zhou J., Mo M.S., Zhu L.H., Liu Y.P., et al. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression. Oncol. Rep 2014, 31:1715-1722.
26. Xu K., Chen Z., Qin C., Song X. miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2. Onco Targets Ther 2014, 7:325-332.
27. Ma C., Qi Y., Shao L., Liu M., Li X., Tang H. Downregulation of miR-7 upregulates Cullin 5 (CUL5) to facilitate G1/S transition in human hepatocellular carcinoma cells. IUBMB Life 2013, 65:1026-1034.
28. Liu S., Zhang P., Chen Z., Liu M., Li X., Tang H. MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells. FEBS Lett 2013, 587:2247-2253.
29. Foekens J.A., Sieuwerts A.M., Smid M., Look M.P., de Weerd V., Boersma A.W., et al. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:13021-13026.
30. Abbas T., Dutta A. p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer 2009, 9:400-414.
31. Sanchez N., Gallagher M., Lao N., Gallagher C., Clarke C., Doolan P., et al. MiR-7 triggers cell cycle arrest at the G1/S transition by targeting multiple genes including Skp2 and Psme3. PLoS ONE 2013, 8. e65671.
32. Zhao X., Dou W., He L., Liang S., Tie J., Liu C., et al. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 2013, 32:1363-1372.